Molecular Docking Study of Antimalarial Drugs

Malaria is one of the most prevalent parasitic diseases in tropical regions of the world over 1 million deaths caused every year. This study is concerned about molecular docking studies of antimalarial drugs for plasmodium falciparum malaria via various bioinformatic tools and software. The result indicates that most of the compounds dock into the active sites of both the wild type and quadruple mutant.